Form 4: Co-Diagnostics President Richard Abbott Executes Stock Transactions Following RSU Vesting

Co-Diagnostics President Richard Abbott acquired 20,000 shares of common stock through the vesting of restricted stock units and sold 6,085 shares to cover tax obligations.

Summary

• Richard Abbott, President of Co-Diagnostics, Inc., engaged in stock transactions on November 23, 2024.
• He acquired 20,000 shares of common stock through the vesting of restricted stock units (RSUs) at a price of $0.00.
• Concurrently, he sold 6,085 shares of common stock at $1.01 per share to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Abbott directly owns 13,915 shares of common stock.
• The RSUs are part of a larger grant of 120,000 units awarded on April 26, 2024, which vest in six equal installments every six months, starting November 23, 2024.

Sentiment

Score: 7

Explanation: The document reflects routine insider transactions related to executive compensation. There is no indication of any negative or positive sentiment, it is a standard process.

Positives

• The vesting of RSUs indicates that the company is fulfilling its long-term incentive plans.
• The 'sell to cover' transaction ensures that tax obligations are met without requiring the executive to use personal funds.

Industry Context

This is a routine transaction related to executive compensation and is common in publicly traded companies. It reflects the vesting schedule of equity-based compensation plans.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as part of executive compensation is a standard practice in the biotechnology and diagnostics industry.
• The 'sell to cover' mechanism for tax obligations is also a common practice to simplify the process for employees and ensure compliance.
• Companies like Abbott Laboratories and Danaher Corporation also use similar equity compensation plans for their executives.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they are related to executive compensation and do not represent a significant change in ownership.
• The transactions are part of the company's compensation plan for its executives.

Next Steps

• The remaining RSUs will continue to vest in equal installments every six months.

Key Dates

Keywords

Co-Diagnostics, Richard Abbott, stock transaction, restricted stock units, RSU, vesting, tax withholding, insider trading, equity incentive plan